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Background
Double blind placebo controlled food challenge (DBPCFC)
is the gold standard for food allergy diagnosis and
outcome measure. However, one difficulty in performing
DBPCFC is the lack of well-characterised and validated
sources of allergens for incurrence into the challenge food
vehicle. Here, we discuss the requirements for this charac-
terisation using the peanut flour used during the EuroPre-
vall project and in ongoing studies.
Methods
2-D PAGE and mass spectrometry (Thermo Fisher Orbi-
trap Elite) was used to provide a molecular characterisa-
tion of allergens in peanut flour. Relative quantitation was
used to determine batch-to-batch variation in allergen
content. Immunoreactivity of the peanut flour material
was assessed using rabbit polyclonal antisera raised to
purified peanut allergens.
Results
2D PAGE profiles of peanut flour showed little variation
between batches. Tandem mass spectrometry showed sev-
eral isoforms of each of the major peanut allergens (Ara h
1, 2, 3, 4, and 6) as well as less abundant allergens (Ara h
7, 8, 9 and 10) were present in the flour samples. Label-
free quantitation was able to demonstrate equivalent
quantities of the allergens and, in some cases, their indivi-
dual sequence isoforms in different batches of peanut
flour. Immunoblotting showed that Ara h 2/6 was unaf-
fected by thermal processing in the peanut ingredient but
Ara h 1 was rendered undetectable.
Conclusion
Molecular profiling methods have shown that a peanut
flour ingredient used for inclusion in oral food challenges
is consistent across several batches. The combination of
physicochemical characterisation of allergens in peanut
ingredients, coupled with an assessment of their immuno-
logical reactivity provide a good basis for quality control
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